Global Cancer Biomarkers Market 2015-2019
Published: Jan 2015 Single User PDF: US$ 2500 Corporate User PDF: US$ 4000 No. of Pages: 89
Order this report by calling +1 888 391 5441 or Send an email to sales@sandlerresearch.org with your contact details and questions if any.
Š SandlerResearch.org/ Contact
Global Cancer Biomarkers Market 2015-2019 Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Biomarkers are becoming an essential part of the drug discovery process. Cancer Biomarkers are proteins or metabolites indicative of tumor state and progression characteristics. They are non-invasive, enable high speed cancer diagnosis and also enhance early cancer detection and screening. The best example of a cancer biomarker is that of prostate specific antigen. PSA is measured in the blood to screen for and monitor treatment for prostate cancer. PSA, as a biomarker helps the doctors to monitor the progress of the cancer. It also helps to evaluate the response of the cancer to the treatment therapy. Analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.26 percent over the period 2014-2019.
Complete Report is Available @ http://www.sandlerresearch.org/global-cancer-biomarkers-market-2015-2019.html .
Š SandlerResearch.org/ Contact
Global Cancer Biomarkers Market 2015-2019 Covered in this Report Global Cancer Biomarkers Market 2015-2019, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cancer Biomarkers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=29739 .
Š SandlerResearch.org/ Contact
Global Cancer Biomarkers Market 2015-2019 Key Regions Americas APAC EMEA Key Vendors Abbott Laboratories Affymetrix Illumina Qiagen Quest Diagnostics Roche Diagnostics
Reach us at + 1 888 391 5441 | sales@sandlerresearch.org
Š SandlerResearch.org/ Contact
Global Cancer Biomarkers Market 2015-2019 Other Prominent Vendors Agendia Agilent Technologies Alere Ambry Genetics Amgen Astellas Pharma US Astex Pharmaceuticals Atossa Genetics Beckman Coulter Becton, Dickinson and Company Biocurex bioMĂŠrieux Read all Vendors Complete Report is Available @ http://www.sandlerresearch.org/global-cancer-biomarkers-market-2015-2019.html .
Š SandlerResearch.org/ Contact
Global Cancer Biomarkers Market 2015-2019 Market Driver Increased Prevalence of Cancer Market Challenge Regulatory and Reimbursement Issues Market Trend Growing Popularity of Companion Diagnostics
Get discount on the Report @ http://www.sandlerresearch.org/inquire-before-buying?rname=29739 .
Š SandlerResearch.org/ Contact
Global Cancer Biomarkers Market 2015-2019 Key Questions Answered in this Report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Inquire Before buying the Report @ http://www.sandlerresearch.org/inquire-before-buying?rname=29739 .
Š SandlerResearch.org/ Contact
Find Us.
Reach us at + 1 888 391 5441 | sales@sandlerresearch.org
Š SandlerResearch.org/ Contact